Blog

A study published in this month’s Lancet has received a lot of media attention, getting recogniztion in such outlets as the Time, UK Telegraph, Businessweek, Marketwatch, and more. The study, Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study, details the results of 42 patients treated with the Sonoblate HIFU system in their phase 2 clinical trial.

Our annual progress report on the activities of the Foundation and the advancing field of focused ultrasound has been released.

While many cases of ET are mild, according to Neal Kassell, MD, chairman of the Focused Ultrasound Surgery Foundation, some patients suffer severely …  http://www.agingwellmag.com/news/ex_040312.shtml

Research activities at the Foundation’s first Center of Excellence, located at the University of Virginia, have once again made national news. The Center’s Research Director Richard J. Price, PhD and his collaborator at Johns Hopkins University, Justin Hanes, PhD, have received a $3.3 million, five-year grant from the National Cancer Institute at the National Institutes of Health. The grant will enable the researchers to continue developing new, focused ultrasound-mediated treatments that deliver drugs across the blood-brain barrier (BBB), the membrane that prevents foreign substances – such as chemotherapies – from entering the brain.